Scott Young | Vice President for Corporate Communications and Investor Relations |
Michael Clayman | Chief Executive Officer |
Dan Deardorf | Senior Vice President of Commercial Operations |
David Arkowitz | Chief Financial Officer |
David Maris | Wells Fargo |
Dan Busby | RBC Capital Markets |
Ann-Hunter Van Kirk | Bank of Montréal |
Elliot Wilbur | Raymond James |
Serge Belanger | Needham |
Carl Byrnes | Northland Securities |
Patrick Trucchio | Berenberg |
Francois Brisebois | Laidlaw |
Bruce Jackson | Benchmark |
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Second Quarter Financial Results Conference Call. My name is Nicole and I will be your coordinator today. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session at the end of today’s call. [Operator Instructions] I will now turn the call over to the company.